Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Stock Information | RedChip

Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Listen to this Section


$5.58
N/A ( 0% ) 41.9K

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Market Data


Open


$5.58

Previous close


$5.58

Volume


41.9K

Market cap


$152.15M

Day range


$5.55 - $5.69

52 week range


$5.26 - $11.92

Insider Ownership Transactions

Total Amount Purchased: -58,439.00 | $ -326,089.62

Date Type Amount Purchased Purchaser
2024-05-02 Sale -2431.00 Raykov Rosty
2024-05-02 Sale -1042.00 Andrade Robert
2024-04-22 Sale -22222.00 Haigh Adrian
2024-04-18 Sale -22222.00 Haigh Adrian
2024-04-16 Sale -22222.00 Haigh Adrian
2024-04-15 Sale -800.00 RALLIS CHRIS A
2024-04-05 Sale -14583.00 Raykov Rosty
2024-04-03 Buy 12500.00 Andrade Robert
2024-04-03 Sale -14584.00 Raykov Rosty
2024-04-03 Buy 29167.00 Raykov Rosty

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 May 21, 2024
4 Insider transactions 1 May 21, 2024
4 Insider transactions 1 May 21, 2024
10-q Quarterly Reports 64 May 14, 2024
def Proxies and info statements 4 May 13, 2024
8-k 8K-related 15 May 09, 2024
4 Insider transactions 1 May 02, 2024
4 Insider transactions 1 May 02, 2024
4/a Other 1 Apr 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.